These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 5338580)
21. Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design. Nanra JS; Timofeyeva Y; Buitrago SM; Sellman BR; Dilts DA; Fink P; Nunez L; Hagen M; Matsuka YV; Mininni T; Zhu D; Pavliak V; Green BA; Jansen KU; Anderson AS Vaccine; 2009 May; 27(25-26):3276-80. PubMed ID: 19200819 [TBL] [Abstract][Full Text] [Related]
22. Identification and susceptibility testing of Staphylococcus aureus by direct inoculation from positive BACTEC blood culture bottles. Diederen BM; Zieltjens M; Wetten H; Buiting AG Clin Microbiol Infect; 2006 Jan; 12(1):84-6. PubMed ID: 16460552 [TBL] [Abstract][Full Text] [Related]
23. Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques. Metz B; Jiskoot W; Mekkes D; Kingma R; Hennink WE; Crommelin DJ; Kersten GF Vaccine; 2007 Sep; 25(39-40):6863-71. PubMed ID: 17707558 [TBL] [Abstract][Full Text] [Related]
24. Protective properties of certain isolated structures from the microbial cell of Staphylococcus aureus. Akatov AK; Prokhorov VYa ; Tolovskaja KR Padiatr Grenzgeb; 1981; 20(1-2):5-11. PubMed ID: 7254875 [No Abstract] [Full Text] [Related]
26. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Kuklin NA; Clark DJ; Secore S; Cook J; Cope LD; McNeely T; Noble L; Brown MJ; Zorman JK; Wang XM; Pancari G; Fan H; Isett K; Burgess B; Bryan J; Brownlow M; George H; Meinz M; Liddell ME; Kelly R; Schultz L; Montgomery D; Onishi J; Losada M; Martin M; Ebert T; Tan CY; Schofield TL; Nagy E; Meineke A; Joyce JG; Kurtz MB; Caulfield MJ; Jansen KU; McClements W; Anderson AS Infect Immun; 2006 Apr; 74(4):2215-23. PubMed ID: 16552052 [TBL] [Abstract][Full Text] [Related]
27. [Inhibitions produced by 8-azaguanine in a toxinogenic strain of Staphylococcus aureus]. Turgeon P; Grimard S; de Repentigny J Can J Microbiol; 1966 Jun; 12(3):588-90. PubMed ID: 5962588 [No Abstract] [Full Text] [Related]
28. [Contributions to the study of the antigens of staphylococci. 3. The immunochemical relationships of 3 strains of Staphylococcus aureus and their mucoid mutants]. Barber C; Taga S Arch Roum Pathol Exp Microbiol; 1965 Mar; 24(1):5-16. PubMed ID: 5877986 [No Abstract] [Full Text] [Related]
29. Microbiological features of Staphylococcus schleiferi subsp. coagulans, isolated from dogs and possible misidentification with other canine coagulase-positive staphylococci. Zdovc I; Ocepek M; Pirs T; Krt B; Pinter L J Vet Med B Infect Dis Vet Public Health; 2004 Dec; 51(10):449-54. PubMed ID: 15606869 [TBL] [Abstract][Full Text] [Related]
30. Staphylococcus aureus antigens and challenges in vaccine development. Middleton JR Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778 [TBL] [Abstract][Full Text] [Related]
31. The activity of teichoic acid of Staphylococcus aureus in skin tests. Wyszomirska Z; Stachów A; Rudzki E Pol Med J; 1969; 8(1):220-6. PubMed ID: 5782163 [No Abstract] [Full Text] [Related]
32. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Meinke A; Henics T; Hanner M; Minh DB; Nagy E Vaccine; 2005 Mar; 23(17-18):2035-41. PubMed ID: 15755567 [TBL] [Abstract][Full Text] [Related]
33. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Wen SX; Teel LD; Judge NA; O'Brien AD Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455 [TBL] [Abstract][Full Text] [Related]
34. [Method of obtaining staphylococcus antigen for use in the immunosorption reaction]. Moskvina EM; Sachkov VI Lab Delo; 1970; 10():623-6. PubMed ID: 4099570 [No Abstract] [Full Text] [Related]
35. [Correlation between Staphylococcus carriage, specific antibody-production and AB0-blood grouping in plasma donors]. Nemyrovs'ka LM; Patoka VV Mikrobiol Z; 2002; 64(2):59-64. PubMed ID: 12190026 [TBL] [Abstract][Full Text] [Related]
36. Biotyping and determination of protein A in Staphylococcus aureus strain of skin origin. Pospisil L; Skalka B; Kabátová A Dermatologica; 1981; 163(4):300-6. PubMed ID: 7030817 [TBL] [Abstract][Full Text] [Related]
37. Vaccination and passive immunisation against Staphylococcus aureus. Schaffer AC; Lee JC Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184 [TBL] [Abstract][Full Text] [Related]
38. Staphylococcal vaccines and immunotherapies. Schaffer AC; Lee JC Infect Dis Clin North Am; 2009 Mar; 23(1):153-71. PubMed ID: 19135920 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic utilization of hemolytically active exosubstances of certain Gram-positive bacteria. II. Detection of staphylococcal hemolysins by means of a pre-purified hemolytically active exosubstance of Corynebacterium pseudotuberculosis. Skalka B; Smola J; Pillich J J Hyg Epidemiol Microbiol Immunol; 1980; 24(1):36-41. PubMed ID: 6995524 [TBL] [Abstract][Full Text] [Related]